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Abstract
Background: Myalgic Encephalomyelitis (ME) is a chronic condition whose status within medicine is the subject of
on-going debate. Some medical professionals regard it as a contentious illness. Others report a lack of confidence
with diagnosis and management of the condition. The genesis of this paper was a complaint, made by an ME
patient, about their treatment by a general practitioner. In response to the complaint, Healthwatch Trafford ran a
patient experience-gathering project.
Method: Data was collected from 476 participants (411 women and 65 men), living with ME from across the UK.
Multinomial logistic regression investigated the predictive utility of length of time with ME; geographic location (i.e.
Manchester vs. rest of UK); trust in GP; whether the patient had received a formal diagnosis; time taken to
diagnosis; and gender. The outcome variable was number of GP visits per year.
Results: All variables, with the exception of whether the patient had received a formal diagnosis, were significant
predictors.
Conclusions: Relationships between ME patients and their GPs are discussed and argued to be key to the effective
delivery of care to this patient cohort. Identifying potential barriers to doctor patient interactions in the context of
ME is crucial.
Keywords: Myalgic Myalgic encephalomyelitis (ME), Chronic fatigue syndrome (CFS), General practitioner (GP) visits
Background
Healthwatch is an independent national champion for
people who use health and social care services in the
UK. In 2015, Healthwatch Trafford received a complaint
from a person who identified as having Myalgic Enceph-
alomyelitis (ME) concerning treatment from their GP
(general practitioner). The complaint opined that others
with ME shared similar negative experiences. Specific-
ally, a lack of patience with ME on the part of healthcare
providers, and a lack of knowledge of ME. In response,
Healthwatch Trafford ran a patient experience-gathering
project, by creating a detailed survey, designed to inves-
tigate, how key factors (i.e., length of time with ME, geo-
graphic location, trust in GP and gender) impacted upon
individual patient relationships with their doctor.
ME as a Condition.
ME is a multisystem condition characterised by fatigue
that endures for at least 6 months and remains unre-
lieved by rest [1–3], it is often debilitating and produces
significant functional impairment [4]. According to the
Centres for Disease Control and Prevention (CDC) cri-
teria [5] diagnosis of ME or CFS (chronic fatigue
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syndrome) as it also known, is dependent on the pres-
ence of at least four of a range of neuropsychiatric and
rheumatologic symptoms [2, 5, 6]. These include im-
paired short-term memory and concentration; head-
aches, sensory disturbances; unrefreshing sleep; muscle
weakness; tender cervical or axillary lymph nodes; ody-
nophagia, gastrointestinal illness, intolerance to extreme
temperatures; and arthralgia [5, 7, 8]. Collectively, symp-
toms characterise serious functional disorder [6].
It is important to note that there is an ongoing debate
about key ME symptoms. Subsequently, different diag-
nostic criteria exist. For example, De Gucht, et al. [9] ac-
knowledged the presence of mental fatigue, yet no
additional somatic symptoms.
Symptoms vary also as a function of age and gender
[6, 8]. Collin et al. [10] reported that adolescents, com-
pared to adults, were less likely to have anxiety and
more likely to display comorbid depression. Recent re-
search [11–13] indicates that ME is a function of wide-
spread inflammation and multi-systematic
neuropathology. As such, there is something of a con-
sensus that, because the term ‘Myalgic Encephalomyeli-
tis’ (ME) indicates underlying pathophysiology, it is
appropriate to refer to the disease as ME rather than
CFS (chronic fatigue syndrome) [11, 14].
Due to the diagnostic issues alluded to above, some
GPs regard ME as a contentious illness, while others re-
port a lack confidence with diagnosis and condition
management [4, 15, 16]. A lack of certainty with regard
to how medical practitioners might refer patients to spe-
cialist services is a further issue reported in the literature
[3, 17]. In terms of prevalence, because there is a lack of epi-
demiological data within the UK estimated ME incidence de-
rives from trends within other countries. Based on these data,
ME incidence is at least 0.2–0.4% [8]. In the UK this represents
1 in 250 of the population or 260,000 in total affected [12].
Studies with broader screening procedures report higher
rates 0.2–6.4% [13]. Additional estimated frequency varies
as a function of diagnostic criteria used (3). Within suffers
there is higher incidence of ME in women and young adults
(6). Although patients often report alleviated symptoms, full
recovery rates are low [7, 14, 15]. Due to symptom com-
plexity and ongoing issues, ME diagnosis and treatment are
health care resource intense [18, 19]. Additionally, ME pro-
duces major socio-economic costs related to functional im-
pairment and the inability to work [17, 20]. Collectively,
direct (e.g., medication, complimentary treatments and pri-
mary and secondary care contacts) and indirect factors
(welfare payments, losses in work productivity, etc.) are fi-
nancially and socially expensive [3, 16, 20]. Hunter et al.
[12] estimated that the true total cost to the UK economy
of ME in 2014/15 was between 1.7 and 4.8 billion pounds.
Central to the diagnosis and treatment of ME is the pa-
tient’s relationship with their GP [4, 18]. However,
‘unhelpful attitudes and ignorance are still widespread in
primary care’, with levels of acceptance and knowledge of
ME amongst GPs reported as often being unsatisfactory
[19]. Nevertheless, an important factor effecting condition
management and outcome is GP visits [13, 20, 21]. Inter-
estingly, multidisciplinary research (e.g., epidemiology,
sociology, and psychology) has highlighted that GP visits
are complex situations, in that there is a link between an
individual’s social relationships, level of GP interaction (in
and out of surgery) and overall health [19, 22].
In particular, Williams et al. [23] proposed that the
groups individuals belong to determine symptom ap-
praisals and responses, health related norms and behav-
iours, coping, social support and clinical outcomes. This
applies to both sides of the doctor-patient interaction.
For instance, Saunders [17] reported that many GP’s
found that a feeling of belonging to a group ‘suffering with
CFS/ME’ is extremely beneficial for many patients. This
sense of affiliation provides an understanding and shared
ownership which enables the GP and patient to partake
on a trustworthy, honest and interactive journey. Alterna-
tively, where doctor’s do not acknowledge, or know, about
living with ME, patients may experience higher levels of
depression, anxiety, and social exclusion [18, 21, 24].
National Institute of Health and Care Excellence [12]
guidelines state that patients should receive a treatment
plan tailored to their symptoms. This guidance derives
from discussion and appraisal of treatment risks and
benefits. Therefore, failure to visit GPs has a potentially
detrimental effect on patient condition management and
outcome. As such, the aim this paper was to examine
factors that might influence patient GP visits (e.g., time
with ME, geographic location, trust in GP, formal diag-
nosis, time to diagnosis and gender) amongst a group of
participants who are living with the condition.
Method
Source of data
Following receipt of the complaint outlined in the open-
ing paragraph, Trafford Healthwatch undertook prelim-
inary investigations that suggested that, anecdotally at
least, complaints about GP attitudes to ME patients were
relatively common. Commencing in April 2015, the on-
line tool Survey Monkey was used to collect information
pertaining to ME patient experiences. The data used in
this analysis is available via the MMU (Manchester
Metropolitan University) repository.
Ethics consent and permissions
In 2017, Trafford Healthwatch contacted MMU to con-
duct an examination of these anonymised data. Prior to
analysis, MMU, Health Psychology & Social Care re-
search ethics committee provided ethical approval. (Eth-
ics Checklist no 1564 18/01/2018). When collecting the
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(anonymous) online survey data Trafford Healthwatch
followed the convention whereby, the researchers having
no direct contact with participants, participants by their
action of completing the survey imply consent.
Participants
In total 476 (411 women and 65 men) individuals with
ME took part in this study, with 463 participants report-
ing a formal diagnosis of ME. Due to the close vicinity
of the authors to Greater Manchester and the specific
interest to ME health services in this area, fifty-nine re-
spondents were from Greater Manchester. To ensure
generalizability to the ME population in the UK [21, 24]
417 participants were from the rest of the UK.
Predictors
The predictor variables were length of time with ME,
whether a patient resided in a Greater Manchester bor-
ough or the rest of the UK (location), trust in the GP,
whether a patient had received a formal diagnosis for
ME (formal diagnosis), the time to diagnosis of ME, and
gender. All predictor variables were categorical (see
Table 1 for information on specific categories).
Outcome
The outcome variable was number of GP visits per year
(i.e. 1–2; 3–4; 5–6; monthly).
Sample size
According to Van Smeden et al. [25] a minimum of 30
observations per independent variable is necessary to
achieve empirical validity when conducting multinomial
logistic regression. Therefore, a minimum sample of 180
provides a sufficient number of observations for testing
the predictive model. This study used a sample of 476
participants, well above the minimum requirement.
Missing data
The survey incorporated a forced response option. This
ensured that participants could not progress through the
survey without completing the previous questions. This
method ensured the dataset did not contain random in-
stances of missing data. Within the sample, 32 partici-
pants failed to complete the survey, indicating an initial
sample of 508. Exclusion of these 32 participants oc-
curred prior to calculation of sample size and data
analysis.
Statistical analysis
To meet the study objectives a multinomial logistic re-
gression was undertaken. For this analysis, the sample
split into four groups based on how frequently partici-
pants visited a GP (1–2 times a year, 3–4 times a year,
5–6 times a year, monthly).
Results
Multinomial logistic regression requires a careful assess-
ment of univariate and multivariate outliers, multicollinear-
ity, and distribution of the error terms. All standardised
values were above − 3.29 and below 3.29, indicating no uni-
variate outliers [26]. The values for Cook’s Distance were
less than 1 (specifically .046) suggesting no multivariate
outliers. Multicollinearity was not an issue, as VIF < 3 and
Tolerance > .1. The P-P plot revealed the error terms
closely and consistently clustered around the diagonal.
Thus, the error terms evinced a normal distribution.
An assessment of sample characteristics (Table 1)
indicated that the majority of participants visited the GP
3–4 times a year and approximately a quarter had ME
between 5 and 10 years. A majority of the sample were
from the rest of the UK, female, and had received a for-
mal diagnosis. However, approximately half of the sam-
ple reported that they did not trust the GP. Time to
diagnosis suggested quite an even spread of the sample
(apart from the ‘less than 3 months’ category which only
a small fraction reported).
Table 1 Categorical characteristics of the sample
Variable Category Number % of the sample
Time with ME 1–2 years 32 6.7
2–5 years 68 14.3
5–10 years 120 25.2
10–15 years 81 17
15–20 years 78 16.4
> 20 years 97 20.4
Location Rest of UK 417 87.6
Manchester borough 59 12.4
Trust in GP Yes 119 25
No 224 47.1
Unsure 133 27.9
Formal diagnosis Yes 463 97.3
No 13 2.7
Time to diagnosis < 3 months 28 5.9
3–6 months 76 16
6 mths-1 year 119 25
1–2 years 77 16.2
2–5 years 78 16.4
> 5 years 98 20.6
Gender Female 411 86.3
Male 65 13.7
Number of GP visits 1–2 times a year 134 28.2
3–4 times a year 161 33.8
5–6 times a year 113 23.7
Monthly 68 14.3
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Chi-square tests of association assessed how each cat-
egorical predictor aligned with the number of GP visits
(see Table 2). Results indicated a significant association
between number of GP visits with length of time with
ME, location, trust in GP, and gender. For length of time
with ME, there appeared to be a general trend support-
ing the notion that the longer participants suffered from
ME, the less frequently they visited the GP. For example,
8.2 and 43.3% of those in the highest category (20 years
plus) visited monthly and 1–2 times a year respectively,
whereas 25 and 12.5% of those in lowest category (1–2
years) visited monthly and 1–2 times a year respectively.
Analysis of location suggested that a greater percentage
of those in Greater Manchester regions visited their GP
more frequently (52.5% visited more than 5 times a
year), whereas 64.1% from the rest of the UK visited the
GP less than 4 times a year. An evident difference
existed concerning trust in GP; 35.3% of participants
who did not trust the GP visited less than 4 times a year
compared with 17.6% who trusted the GP, whereas
11.6% who did not trust the GP visited monthly com-
pared with 21% of those who trusted the GP. Analysis of
gender indicated that women (40.3%) were more likely
to visit their GP more than 5 times a year compared
with men (23.1%).
A multinomial logistic regression evaluated the predic-
tion of membership into GP visit categories (1–2 times a
year, 3–4 times a year, 5–6 times a year, monthly). The
reference group was 1–2 times a year. Analyses revealed
a good model fit (discrimination among groups) on the
Table 2 Associations between predictor variables and number of GP visits
Number of GP visits a year
1–2
(n = 134)
3–4
(n = 161)
5–6
(n = 113)
Monthly
(n = 68)
Test of association with GP visits
Variable Category n (%) n (%) n (%) n (%) Total n χ2 test p value
Time with ME 1–2 years 4 (12.5) 12 (37.5) 8 (25) 8 (25) 32
2–5 years 14 (20.6) 25 (36.8) 19 (27.9) 10 (14.7) 68
5–10 years 34 (28.3) 34 (28.3) 32 (26.7) 20 (16.7) 120
10–15 years 17 (21) 27 (33.3) 25 (30.9) 12 (14.8) 81
15–20 years 23 (29.5) 31 (39.7) 14 (17.9) 10 (12.8) 78
> 20 years 42 (43.3) 32 (33) 15 (15.5) 8 (8.2) 97
Total time with ME 28.062 .021*
Location Rest of UK 125 (30) 142 (34.1) 94 (22.5) 56 (13.4) 417
Manchester borough 9 (15.3) 19 (32.2) 19 (32.2) 12 (20.3) 59
Total location 7.791 .050*
Trust in GP Yes 21 (17.6) 43 (36.1) 30 (25.2) 25 (21) 119
No 79 (35.3) 67 (29.9) 52 (23.2) 26 (11.6) 224
Unsure 34 (25.6) 51 (38.3) 31 (23.3) 17 (12.8) 133
Total trust in GP 16.261 .012*
Formal diagnosis Yes 129 (27.9) 157 (33.9) 111 (24) 66 (14.3) 463
No 5 (38.5) 4 (30.8) 2 (15.4) 2 (15.4) 13
Total diagnosis .946 .814
Time to diagnosis < 3 months 7 (25) 13 (46.4) 5 (17.9) 3 (10.7) 28
3–6 months 25 (32.9) 31 (40.8) 15 (19.7) 5 (6.6) 76
6 mths-1 year 31 (26.1) 44 (37) 22 (18.5) 22 (18.5) 119
1–2 years 25 (32.5) 21 (27.3) 22 (28.6) 9 (11.7) 77
2–5 years 22 (28.2) 19 (24.4) 21 (26.9) 16 (20.5) 78
> 5 years 24 (24.5) 33 (33.7) 28 (28.6) 13 (13.3) 98
Total time to diagnosis 19.458 .194
Gender Female 106 (25.8) 139 (33.8) 105 (25.5) 61 (14.8) 411
Male 28 (43.1) 22 (33.8) 8 (12.3) 7 (10.8) 65
Total gender 10.753 .013*
Note. * indicates p < .05
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basis of length of time with ME, location, trust in GP,
formal diagnosis, time to diagnosis of ME, and gender,
χ2 (483, N = 476) = 495.140, p = .341 (using deviance cri-
terion), Nagelkerke R2 = .183. Similarly, a test of the full
model vs. the constant model revealed a significant re-
sult, χ2 (45, N = 476) = 88.760, p < .001, suggesting that
the predictors as a group satisfactorily distinguished be-
tween the GP visits categories.
The Wald statistic (see Table 3) indicated that com-
pared to individuals who visited the GP 1–2 times a
year, individuals who visited the GP 3–4 times a year
were significantly more likely to have suffered from ME
for 2–5 years (OR = 2.695) and less likely to be from a
Greater Manchester borough (OR = .411). Individuals
who visited the GP 5–6 times a year were significantly
more likely to have had ME between 1 and 15 years (1–
2 years: OR = 8.771; 2–5 years: OR = 5.369; 5–10 years:
OR = 3.180; 10–15 years = 4.310) and to be female (OR =
3.686). Individuals visiting 5–6 times a year were also
less likely to be from a Greater Manchester borough
(OR = .321) and for time to diagnosis to be 3–6months
(OR = .328) compared to the reference group. Lastly, in-
dividuals who visited the GP monthly were significantly
more likely to have had ME between 1 and 15 years (1–
2 years, OR = 11.632; 2–5 years: OR = 4.633; 5–10 years:
OR = 3.397; 10–15 years: OR = 3.372), to trust the GP
(OR = 2.503), and to be female (OR = 2.849). Individuals
visiting monthly were furthermore less likely to be from
a Greater Manchester borough (OR = .247) and for time
to diagnosis to be 3–6months (OR = .205).
Discussion
A significant proportion of ME suffers reported unsatis-
factory relationships with their GP. This finding indicated
that ME patients experience a troubled relationship with
their primary health contact. Indeed, approximately half of
the surveyed participants did not trust their GP. Trust was
only evident within the monthly GP visit group. These are
important outcomes because lack of trust can negatively
affect the number of times patients visit GPs and condi-
tion management [17, 21, 27]. One strategy with the po-
tential to address this issue is for GPs to cultivate a sense
of “we-ness”. Shared GP/ME patient group membership
and common goals may facilitate respect and trust [4, 24].
Building rapport with this cohort is vital.
Potential barriers to positive in-group inclination are
depersonalization and stereotyping. From the perspective
of GPs, the ME patient group are problematic because
ME diagnosis is often considered contentious [15, 24],
prevalence is low, and, importantly, ME is absent from
the Quality and Outcome Framework [3]. These factors
combine to make ME management and treatment chal-
lenging and time consuming [15, 16, 20]. Within the
present study, formal diagnosis and time to diagnosis
Table 3 Multinomial logistic regression differentiating 1–2 GP visit a year (n = 134) from 3 to 4 GP visits, 5–6 GP visits and monthly
GP visits
Note: References categories: length of time with ME =more than 20 years, location =Manchester borough, trust in GP = unsure, formal diagnosis of ME = no, time
to diagnose of ME =more than 5 years, genders = male; * indicates p < .05
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had little effect on ME patient visits. The notable excep-
tion was the 3–6 month category, where diagnosis was
associated with increased GP visits in the 5–6 a year and
monthly categories. These results suggest this is an im-
portant period for diagnosis. Subsequent research should
examine this further.
Moreover, the groups that patients understand them-
selves as belonging to potentially influences symptom ap-
praisal/responses, health related norms/behaviours,
coping, social support and clinical outcomes [22, 23].
Thus, from a health and well-being perspective, it is clear
that individual’s relationships, and identification, with
their medical and social care providers are of vital import-
ance. Indeed, for people living with chronic conditions,
the GP relationship is a crucial factor [4, 18, 19]. As such,
the functionality of the doctor patient interaction is funda-
mental to individual well-being. Mutual respect is a core
facet at the heart of this relationship [3, 17].
Illustratively, St Claire and Clucas [27] observed that
patients reported several affirmative outcomes when
they perceived their doctor as respectful (i.e., greater sat-
isfaction, intention to adhere to advice, and inclination
to revisit). Thus, positive patient regard not only en-
hances the doctor and patient interaction, but also im-
proves patient prognosis by reducing symptoms and
facilitating healthy behaviours. In this context, commu-
nication and skills training may help to enhance GP
interaction with ME patients. Succeeding studies should
assess this area.
The results of the present study also revealed a nega-
tive relationship between length of ME and frequency of
GP visits, as the length of the condition extended pa-
tients reported fewer GP visits. One way to understand
this is to build conceptually on a recognition of the im-
portance of communication. Consistent with the positive
link between trust and GP visits [3, 17], De Carvalho
Leite et al. [28] reported that inadequate communication
between patients and professionals was often a barrier to
care. With a significant proportion of English GPs re-
ported as being sceptical of ME as a diagnosis [3, 14], it
is not surprising that patients frequently report their at-
tempts to access services as ‘exhausting, demoralising
and isolating’ [15, 20, 28].
In line with this qualitative literature, our findings re-
veal that over time ME patients engage less with medical
practitioners. Although, the reasons for this are currently
unclear, this finding suggests that improved doctor and
ME patient communication and monitoring is advisable.
This would help to track number of appointments
attended, frequency, and points at which attendance
cease. Maintaining and engaging with treatment is vital
to condition management and well-being. A general
remedy for ineffective communication is to provide em-
pathic, personalised and co-ordinated support from
health and social services [3, 17, 28]. Additionally, when
ME patients stop visiting their GP it is recommended
that reasons for non-attendance are sought. Collation
and consideration of such feedback could usefully in-
form subsequent investigation.
This study found also that gender was an important fac-
tor. Specifically, women were more likely to visit their GP
than men. Indeed, analysis of gender revealed that women
were more likely to visit their GP more than 5 times a year
(40.3%) compared with men (23.1%). Psychology has long
recognised the importance of gender [6, 29, 30] which is
most usefully considered as a function of social and devel-
opmental factors rather than as an essentialist actuality.
Sandberg, Pasterski, and Callens, [31] for example argued
that different psychosexual developmental experiences
manifest in women as a sense of self that is relational,
whereas men’s sense of self is more independent and less
contingent on interpersonal connection [5, 23, 30].
Gender differences in health service access have re-
ceived relatively little attention in the UK. When studies
evaluate gender, they focus typically on women’s issues,
particularly male privilege [6, 32]. The present article
highlighted the fact that men also possess important
healthcare needs. Hence, effective provision needs to
recognise the needs of all gender groups. Haslam [33]
argues that, from clinical and health perspectives, in
order to engage usefully with identity (including gender)
researchers need to work with an individual’s sense of
self rather than across it. Study findings recommend that
health care professionals would benefit from increased
awareness of this issue.
One mechanism through which gender differences
may arise is stereotyping. Stereotyping defines appropri-
ate and relevant behaviours within particularly contexts
and guides expectations [30, 34, 35]. For example, the
typical male stereotype implies that a person has psycho-
logical capability, goal-orientation, self-confidence as
well as social dominance [30, 35]. This implies that men
are resilient [34]. Moreover, the male stereotype posi-
tions ‘real’ men as being invulnerable [29, 35].
Importantly this process of categorization links to
existing social relations, [22, 23, 36], including relation-
ships with medical service providers [4, 6]. The norms of
stoicism and control associated with masculinity often
prevent men from seeking healthcare where they believe
they risk lapsing into a passive and/or ‘feminine’ sick
role that is associated with weakness [32]. The argument
presented in this paper, driven by the finding that men
are less likely to be engaged with their GP, is that med-
ical practitioners need to engage with men, recognize
and harness these male identities/stereotypes and norms
by working with, rather than across them [4, 22, 33].
A final important variable was geographic location.
Isakson et al. [37] contend that when there are
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preventable health inequities between people, the distri-
bution of health resources that shape the inequity re-
quire consideration. Such questioning is the raison d’être
of Healthwatch networks. Indeed, Healthwatch Trafford
commissioned this patient experience gathering exercise
because of reported patient issues within the Greater
Manchester region. Specifically, they were keen to deter-
mine whether there were variances in ME treatment
compared with the rest of the UK. Results revealed a sig-
nificant difference. Greater Manchester residents living
with ME visited their GPs more frequently than those
living in the rest of the country did. Future research
should attempt to unpack this finding in order to iden-
tify what this might be.
Conclusions
Overall, study findings should usefully inform a range of
salient and potentially crucial social relationships and in-
teractions that affect the lives of those living with ME.
Significant groups include the clinical dyad of GP and
patient, gendered groups (i.e. men and women), the pa-
tient group (i.e. those living with ME), and the position
of those living with ME vis-a-vis wider society (e.g. em-
ployers, social welfare, etc.). Haslam [33] argues power-
fully that to harness the power of relationships we need
to work with the understandings that people have of
themselves. The patient experiences presented in this
paper suggests that there is ample scope in the field of
ME for medical practitioners to harness that advice to
their patient’s advantage.
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